Last reviewed · How we verify

NCT04567381

An Outcome Evaluation of the Project CHANGE-MS Violence Intervention Program

Completed NA Last updated 14 February 2022
What this trial tests

NA trial testing Enhanced Services in Violence in 400 participants. Completed in 31 October 2021.

Timeline
1 August 2018
Primary endpoint
31 October 2020
31 October 2021

Quick facts

Lead sponsorMedstar Health Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment400
Start date1 August 2018
Primary completion31 October 2020
Estimated completion31 October 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Medstar Health Research Institute

Who can join

18 and older, male only, with Violence or Recidivism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective randomized control trial design to evaluate the effectiveness of a hospital based violence intervention program. Participants will be randomized into a "treatment as usual" group who will receive written referrals for services and an "enhanced services" group who will receive intensive case management over a one year period. Primary outcome will be rate of violent reinjury after enrollment. Follow-up will be for one year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Enhanced Services

Trials testing the same drug.

Other recruiting trials for Violence

Currently open trials in the same condition.

Other Medstar Health Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04567381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing